The diabetes clinical research program at SUNY Upstate Medical University is led by Ruth S. Weinstock,
MD PhD, a highly respected researcher and SUNY Distinguished Service Professor . Sheis/has been
Principal Investigator or Co-Investigator on greater than 80 NIH-sponsored as well as not-for-profit and
industry sponsored clinical trials related to diabetes, and has approximately 160 original peer-reviewed
research publications. Currently, the diabetes research team is participating in approximately 20 diabetesrelated clinical research projects, which are supported by NIDDK, industry sponsors, JDRF (Juvenile
Diabetes Research Foundation) and the Helmsley Charitable Trust. UMU’s Joslin Diabetes Center, which
also cares for patients with other endocrine disorders, serves over 20 counties, and provides a team
approach for the management of youth and adults with diabetes and other endocrine disorders.
Approximately 35,000 visits are anticipated this year, providing a large patient base for the recruitment
for clinical trials in type 1 and type 2 diabetes as well as osteoporosis and other metabolic bone diseases.
The Clinical Research Unit (CRU) at SUNY Upstate Medical University, is a well-equipped and
high functioning core facility dedicated to conducting outpatient clinical research funded by
government, industry, or not-for-profit foundations. The CRU is staffed by dedicated,
experienced research nurses and study coordinators, as well as a research Physician Assistant
and laboratory technician. The CRU is available for all Upstate faculty, and currently services
over 50 clinical trials. Dr. Ruth Weinstock serves as Medical Director.
SUNY Upstate Medical University clinicians and Center for Global Health and Translational Science
(CGHATS) research leaders, Mark Polhemus, MD and Timothy Endy, MD, have been working together on
the development of Controlled Human Infection Models for Dengue and Malaria. Over the course of the
next year, if all goes as expected, they will have identified a safe challenge for Industry’s newly developed
Dengue and Malaria vaccines, in clinical trial.
The SUNY Upstate Medical University’s Center for Global Health and Translational Science
(CGHATS) is a research center focused on developing products for diseases of the developing
world. It incorporates the efforts and programs of both basic science researchers and clinical
investigators across the entire continuum of translational research. This Center has partnerships
with the Department of Defense, industry, academic institutions, and philanthropists, raises
research funds, conducts novel research, and develops new diagnostics, drugs, and vaccines.
The translational research continuum includes discovery research, pre-clinical laboratory
studies, animal studies and regulated human use trials.
CGHATS has an experientially rich team of investigators, regulatory personnel and support staff
with broad knowledge base in global health and translational research. CGHATS has focused
much research effort on epidemiology of disease, disease mapping, and development of
vaccines and diagnostics, currently involved in several Phase 1 and Phase 2 clinical trials, for
diseases of greatest threat to travelers and the military, including dengue, rabies, and malaria.
SUGGEST ADD NEUROLOGY trials. Check with Mary Lou, Dr. Jubelt, Dr. Brashaw etc.
AND ADD CANCER TRIALS (check with Dr. Graziano and others) and PSYCHIATRY Clinical research (Dr.
Glatt and others)
Suggest adding Geriatrics (check with Dr. Sharon Brangman)